{"id":"https://openalex.org/W30797005","doi":null,"title":"Secondary hyperparathyroidism exacerbation: a rare side-effect of interferon-alpha?","display_name":"Secondary hyperparathyroidism exacerbation: a rare side-effect of interferon-alpha?","publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W30797005","mag":"30797005","pmid":"https://pubmed.ncbi.nlm.nih.gov/10230558"},"language":"en","primary_location":{"id":"pmid:10230558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10230558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical nephrology","raw_type":"Case Reports"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050882369","display_name":"Jes\u00fas Calvi\u00f1o","orcid":"https://orcid.org/0000-0003-3330-2673","observed_orcids":["https://orcid.org/0000-0003-3330-2673"]},"institutions":[{"id":"https://openalex.org/I4210096311","display_name":"Complejo Hospitalario Universitario de Santiago","ror":"https://ror.org/00mpdg388","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096311"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J Calvino","raw_affiliation_strings":["Division of Nephrology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain","institution_ids":["https://openalex.org/I4210096311"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R Romero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Romero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031465189","display_name":"Jos\u00e9 Manuel Su\u00e1rez Pe\u00f1aranda","orcid":"https://orcid.org/0000-0003-4033-3638","observed_orcids":["https://orcid.org/0000-0003-4033-3638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M Su\u00e1rez-Pe\u00f1aranda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000815687","display_name":"Victor Arcocha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Arcocha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085871782","display_name":"Xos\u00e9 M. Lens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"X M Lens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089494128","display_name":"Javier Mardaras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Mardaras","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021048466","display_name":"Daniel Novoa","orcid":"https://orcid.org/0009-0002-3325-4405","observed_orcids":["https://orcid.org/0009-0002-3325-4405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Novoa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5040381410","display_name":"Domingo Sanchez-Guisande","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D S\u00e1nchez-Guisande","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3858,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.62848853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"51","issue":"4","first_page":"248","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.47609999775886536,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.47609999775886536,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.41499999165534973,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.013000000268220901,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/secondary-hyperparathyroidism","display_name":"secondary hyperparathyroidism","score":0.9580000042915344},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9010000228881836},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.7310000061988831},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.8880000114440918},{"id":"https://openalex.org/keywords/peritoneal-dialysis","display_name":"peritoneal dialysis","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hypocalcemia","display_name":"hypocalcemia","score":0.9229999780654907},{"id":"https://openalex.org/keywords/parathyroid-hormone","display_name":"parathyroid hormone","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-withdrawal","display_name":"drug withdrawal","score":0.46700000762939453}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9558500051498413},{"id":"https://openalex.org/C2778838027","wikidata":"https://www.wikidata.org/wiki/Q3622611","display_name":"Secondary hyperparathyroidism","level":4,"score":0.7649413347244263},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.7303321361541748},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.675932765007019},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6575568914413452},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.5543060302734375},{"id":"https://openalex.org/C2775945674","wikidata":"https://www.wikidata.org/wiki/Q1344835","display_name":"Hyperparathyroidism","level":2,"score":0.5249545574188232},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.445059597492218},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4388408660888672},{"id":"https://openalex.org/C2776029263","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Hepatitis","level":2,"score":0.4289875626564026},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4126875698566437},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.39943891763687134},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39514192938804626},{"id":"https://openalex.org/C2781208988","wikidata":"https://www.wikidata.org/wiki/Q202476","display_name":"Parathyroid hormone","level":3,"score":0.11726510524749756},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001706","descriptor_name":"Biopsy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006962","descriptor_name":"Hyperparathyroidism, Secondary","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D010530","descriptor_name":"Peritoneal Dialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10230558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10230558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical nephrology","raw_type":"Case Reports"},{"id":"mag:30797005","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10230558","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":70,"referenced_works":["https://openalex.org/W2146553399","https://openalex.org/W2064871488","https://openalex.org/W2398714030","https://openalex.org/W2798238147","https://openalex.org/W2790098086","https://openalex.org/W2755983908","https://openalex.org/W2014985275","https://openalex.org/W2002471954","https://openalex.org/W2147215679","https://openalex.org/W2567706609","https://openalex.org/W2117389328","https://openalex.org/W1980867740","https://openalex.org/W2068211996","https://openalex.org/W1988282587","https://openalex.org/W2069134412","https://openalex.org/W1968827772","https://openalex.org/W2067609431","https://openalex.org/W2020159290","https://openalex.org/W2508274757","https://openalex.org/W2081612482","https://openalex.org/W2028372058","https://openalex.org/W2035123591","https://openalex.org/W2079294255","https://openalex.org/W1999866520","https://openalex.org/W2081482599","https://openalex.org/W2033799390","https://openalex.org/W2462226888","https://openalex.org/W2032985786","https://openalex.org/W2523908805","https://openalex.org/W2339623433","https://openalex.org/W2543797400","https://openalex.org/W2312214856","https://openalex.org/W2139926893","https://openalex.org/W1994554288","https://openalex.org/W2133941148","https://openalex.org/W2320406675","https://openalex.org/W2049477761","https://openalex.org/W1998120973","https://openalex.org/W1996766631","https://openalex.org/W2002063692","https://openalex.org/W2081149494","https://openalex.org/W2029822559","https://openalex.org/W1996157979","https://openalex.org/W2419146835","https://openalex.org/W2029378620","https://openalex.org/W2487869924","https://openalex.org/W1996185517","https://openalex.org/W2088854812","https://openalex.org/W2515725894","https://openalex.org/W2550089785","https://openalex.org/W2346656303","https://openalex.org/W2032017512","https://openalex.org/W2021358274","https://openalex.org/W2099753445","https://openalex.org/W1983878125","https://openalex.org/W2009789896","https://openalex.org/W2059910836","https://openalex.org/W2003648205","https://openalex.org/W2008134720","https://openalex.org/W2041911040","https://openalex.org/W2108237602","https://openalex.org/W2531660456","https://openalex.org/W2061266901","https://openalex.org/W2088659153","https://openalex.org/W1985901190","https://openalex.org/W1811005764","https://openalex.org/W2263921196","https://openalex.org/W2067764537","https://openalex.org/W2291154735","https://openalex.org/W2168478591"],"related_works":["https://openalex.org/W2418905308","https://openalex.org/W2050207472","https://openalex.org/W2124098035","https://openalex.org/W2977498556","https://openalex.org/W299753989","https://openalex.org/W2084736884","https://openalex.org/W2102124614","https://openalex.org/W1761972135","https://openalex.org/W4231582966","https://openalex.org/W2337949056"],"abstract_inverted_index":{"Recombinant":[0],"human":[1],"interferon":[2],"alpha":[3],"(alpha":[4],"IFN)":[5],"is":[6,125],"the":[7,30,40,119],"only":[8],"treatment":[9,68],"with":[10,51,69,80],"proven":[11],"benefit":[12],"for":[13],"chronic":[14,52],"hepatitis":[15,54],"C":[16],"virus":[17],"(HCV)":[18],"infection.":[19],"Nevertheless":[20],"its":[21],"use":[22],"in":[23],"some":[24,128],"susceptible":[25],"individuals":[26],"has":[27],"led":[28],"to":[29,56,73],"development":[31],"or":[32],"aggravation":[33],"of":[34,42,94,102],"different":[35],"autoimmune":[36,116],"conditions.":[37],"We":[38],"report":[39],"case":[41,124],"a":[43,91,99],"20":[44],"year":[45],"old":[46],"woman":[47],"on":[48],"peritoneal":[49],"dialysis":[50],"lobular":[53],"secondary":[55,85],"HCV":[57],"infection":[58],"who":[59],"developed":[60],"de":[61],"novo":[62],"psoriasis":[63],"9":[64],"months":[65],"after":[66,107],"starting":[67],"alpha-IFN.":[70],"In":[71],"addition":[72],"psoriasis,":[74],"alpha-IFN":[75],"prescription":[76],"was":[77],"also":[78],"concurrent":[79],"an":[81,114],"unexpected":[82],"and":[83,98,127],"refractory":[84],"hyperparathyroidism":[86],"exacerbation":[87],"initially":[88],"characterized":[89],"by":[90],"marked":[92],"reduction":[93],"serum":[95],"calcium":[96],"levels":[97],"consequential":[100],"increase":[101],"PTH.":[103],"Both":[104],"complications":[105],"disappeared":[106],"drug":[108],"withdrawal.":[109],"The":[110,123],"clinical":[111],"sequence":[112],"makes":[113],"alpha-IFN-induced":[115],"side":[117],"effect":[118],"most":[120],"plausible":[121],"hypothesis.":[122],"discussed":[126],"possible":[129],"etiopathogenic":[130],"factors":[131],"are":[132],"briefly":[133],"reviewed.":[134]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}